Subject: Survey to understand the perception regarding Dietary Management and Medical Nutrition Therapy Usage in diabetes patients (MNT-DID Survey)
Dietary modifications that limit hyperglycemia after meals are particularly important if patients are to fulfil their glycemic targets and stay healthy. Dietary ingredients including lactose and fiber have been demonstrated to lower glycemic response and have favorable impacts on PPG and HbA1c levels. It has been shown in literature that several dietary methods using diverse nutritional compositions, such as low carbohydrate, low-GI, Mediterranean, and high-protein diets, are beneficial in improving multiple markers of cardiovascular risk management in patients with diabetes. However, individuals with diabetes still have difficulty beginning and maintaining dietary changes.
According to a systematic review and meta-analysis it has shown that ready-to-use formula or a Diabetic Specific Nutrition Supplement (DSNS) included in the overall lifestyle management plan, significantly lowers postprandial blood glucose, peak blood glucose concentration, area under the curve for glucose and glycosylated hemoglobin (HbA1C).
Currently, limited data is available regarding usage of MNT in diabetic patients, and this study is designed to understand the perception of healthcare professional on usage of dietary management and MNT in type 2 DM patients in India.
We invite you to participate in this survey bearing protocol number SP/CVD/MNT-DID/RWE/22/2023. On acceptance, you will need to capture the relevant data as mentioned in the standard Data Collection Form (DCF) provided, from the patient’s medical records (case papers and investigational reports – hereafter referred as source documents).
We would recommend you to capture data fulfilling the criteria as outlined in the protocol and whose relevant laboratory investigations are available for the preceding 3 months. The DCF will capture all data in de-identified form and any identifiable parameters which may potentially disclose the identity of the patient such as name or address will strictly not be captured so as to ensure we maintain patient confidentiality. We would encourage you to carefully fill all available information to the fullest as recommended in the DCF.
In alignment with good clinical research practices, an independent Contract Research Organization (CRO) will monitor this study and do the source data verification of the data captured in the DCF with copies of the patients’ source medical records (case papers and investigational reports) to ensure that the data entered in the DCFs are accurate and in alignment with the patients’ medical records. The study is approved by independent ethics committee.
If you agree to participate in the said study, we would request you to sign and return the enclosed reply along with your visiting card for accuracy of records.
|
}}){kind=logo}